Key terms

About HUM

Humana Inc. engages in the provision of health insurance services. It operates through the Insurance and CenterWell segments. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which refer to as state-based contracts. The CenterWell segment represents payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest HUM news

Today 7:56am ET Jefferies Sticks to Its Buy Rating for Humana (HUM) Today 7:55am ET Humana (HUM) Receives a Rating Update from a Top Analyst Today 7:10am ET Truist Financial Remains a Hold on Humana (HUM) Today 6:55am ET RBC Capital Sticks to Its Buy Rating for Humana (HUM) Today 5:50am ET Analysts Conflicted on These Healthcare Names: Travere Therapeutics (TVTX), Humana (HUM) and Merck & Company (MRK) Today 5:38am ET Humana’s Strong Performance and Positive Outlook Affirm Buy Rating Yesterday 9:25pm ET Humana’s Buy Rating Affirmed Amidst Long-Term Growth Potential and Competitive Positioning Yesterday 9:10am ET Analysts Have Conflicting Sentiments on These Healthcare Companies: Humana (HUM), Boston Scientific (BSX) and Biogen (BIIB) Yesterday 6:52am ET Humana Inc Reveals Quarterly Financial Performance and Projections Yesterday 6:44am ET Humana no longer believes $6-$10 of adjusted EPS growth is appropriate for 2025 Yesterday 6:32am ET Humana backs FY24 adjusted EPS view ‘approximately’ $16.00, consensus $16.36 Yesterday 6:30am ET Humana reports Q1 adjusted EPS $7.23, consensus $6.12 Apr 23 8:25pm ET Notable companies reporting before tomorrow’s open Apr 23 1:18pm ET Notable companies reporting before tomorrow’s open Apr 23 9:04am ET Humana expands use of Cohere Health’s authorization platform Apr 22 11:30am ET Jefferies says Cigna acquisition of Humana ‘seems plausible’ near $420 per share Apr 18 10:29am ET Hospital survey weakened ‘dramatically’ in March, says TD Cowen Apr 16 9:56am ET Early notable gainers among liquid option names on April 16th Apr 15 10:37am ET Centene rises, Molina slides following Florida’s managed Medicaid awards Apr 15 6:16am ET Molina Healthcare price target lowered to $410 from $440 at Wells Fargo Apr 15 6:15am ET Centene price target raised to $93 from $89 at Wells Fargo Apr 15 6:06am ET Wells Fargo Keeps Their Buy Rating on Humana (HUM) Apr 08 6:17am ET Humana (HUM) Receives a Buy from Wells Fargo Apr 08 5:48am ET Humana price target raised to $326 from $310 at Barclays Apr 04 6:31am ET Thursday Macro & Markets Update – 04.04.24 Apr 04 5:40am ET Analysts Offer Insights on Healthcare Companies: Illumina (ILMN) and Humana (HUM) Apr 02 10:58am ET Insurer stocks tumble as Medicare Advantage rates disappoint Apr 02 10:00am ET Humana falls -9.8% Apr 02 9:53am ET Estee Lauder upgraded, Petco downgraded: Wall Street’s top analyst calls Apr 02 9:47am ET Humana falls -10.2% Apr 02 9:25am ET Hold Rating on Humana Amid Subdued Medicare Advantage Rate Increase Apr 02 8:31am ET Humana downgraded to Neutral from Buy at BofA

No recent press releases are available for HUM

HUM Financials

1-year income & revenue

Key terms

HUM Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

HUM Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms